Anti-CD4/CyA therapy causes prevention of autoimmune but not allogeneic destruction of grafted islets in BB rats

Transplant Proc. 1997 Jun;29(4):2163-5. doi: 10.1016/s0041-1345(97)00276-5.

Authors

B Kuttler¹, K Rösing, H J Hahn

Affiliation

¹ Institute of Diabetes, G. Katsch Karisburg, University of Greifswald, Germany.

PMID: 9193572
DOI: 10.1016/s0041-1345(97)00276-5

No abstract available

MeSH terms

Animals
Antibodies, Monoclonal / therapeutic use*
Autoimmunity
Blood Glucose / metabolism
CD4 Antigens / immunology*
CD4-Positive T-Lymphocytes / immunology
Cyclosporine / therapeutic use*
Diabetes Mellitus, Type 1 / blood
Diabetes Mellitus, Type 1 / surgery*
Graft Rejection / prevention & control
Islets of Langerhans / immunology*
Islets of Langerhans / physiology
Major Histocompatibility Complex
Rats
Rats, Inbred BB
Rats, Inbred Lew
Transplantation, Homologous / immunology*
Transplantation, Isogeneic / immunology

Substances

Antibodies, Monoclonal
Blood Glucose
CD4 Antigens
Cyclosporine